Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Hip Arthroplasty
NCT ID: NCT00864409
Last Updated: 2009-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
12 participants
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Local Infiltration Anesthesia With Ropivacaine on Pain After Primary Total Hip Arthroplasty
NCT02359136
Local Infiltration Analgesia in Bilateral Knee Arthroplasty - Efficacy of Subcutaneous Wound Infiltration With Local Anesthetic
NCT00927225
Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty
NCT02299271
Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion
NCT01108562
Local Infiltration Analgesia in Total Knee Arthroplasty
NCT03206554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hip 1
high volume local anesthetic infiltration
ropivacaine 0,2%
Local wound infiltrtation with 170 mL ropivacaine 2 mg/mL
Hip 2
saline.9%
Wound infiltration with 170 mL sterile saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ropivacaine 0,2%
Local wound infiltrtation with 170 mL ropivacaine 2 mg/mL
saline.9%
Wound infiltration with 170 mL sterile saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to speak and understand Danish
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hvidovre University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hvidovre University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hviovre University Hospital
Hvidovre, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KF-01-2006-4062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.